Amrutanjan Health Care Limited Stock Price Today (NSE: AMRUTANJAN)
Fundamental Score
Amrutanjan Health Care Limited Share Price — Live NSE/BSE Price, Fundamentals & Analysis
Amrutanjan Health Care Limited share price today is ₹490.40, up +0.16% on NSE/BSE as of 16 September 2026. Amrutanjan Health Care Limited (AMRUTANJAN) is a Small-cap company in the Pharmaceuticals sector with a market capitalisation of ₹1.42K (Cr). The 52-week high for AMRUTANJAN share price is ₹772.00 and the 52-week low is ₹476.50. At a P/E ratio of 26.27x, AMRUTANJAN is currently trading below its industry average P/E of 34.89x. The company has a Return on Equity (ROE) of 16.62% and a debt-to-equity ratio of 0.00.
Amrutanjan Health Care Limited Share Price Chart — NSE/BSE Historical Performance
Amrutanjan Health Care Limited share price chart: -5.10% return over the past month. 52-week high ₹772.00, 52-week low ₹476.50.
Amrutanjan Health Care Limited — Last 10 Trading Days
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| ₹489.60 | ₹493.70 | ₹476.50 | ₹490.40 | 54.79K (Cr) | |
| ₹489.00 | ₹494.85 | ₹485.00 | ₹489.60 | 26.95K (Cr) | |
| ₹492.00 | ₹498.00 | ₹485.05 | ₹490.95 | 73.52K (Cr) | |
| ₹504.00 | ₹508.50 | ₹492.20 | ₹493.25 | 53.90K (Cr) | |
| ₹500.45 | ₹512.00 | ₹494.00 | ₹504.00 | 74.61K (Cr) | |
| ₹503.00 | ₹503.85 | ₹493.00 | ₹500.45 | 42.17K (Cr) | |
| ₹505.40 | ₹505.45 | ₹495.60 | ₹500.30 | 63.40K (Cr) | |
| ₹509.00 | ₹516.00 | ₹500.10 | ₹505.45 | 41.07K (Cr) | |
| ₹502.75 | ₹515.45 | ₹502.75 | ₹507.35 | 67.87K (Cr) | |
| ₹499.50 | ₹510.90 | ₹499.50 | ₹500.25 | 33.54K (Cr) |
Amrutanjan Health Care Limited — Last 12 Months Price History
| Month | Open | High | Low | Close | Change |
|---|---|---|---|---|---|
| ₹513.00 | ₹516.00 | ₹476.50 | ₹490.40 | -4.41% | |
| ₹520.00 | ₹549.90 | ₹482.80 | ₹509.35 | -2.05% | |
| ₹546.10 | ₹567.40 | ₹503.60 | ₹515.00 | -5.69% | |
| ₹566.95 | ₹577.45 | ₹531.00 | ₹547.95 | -3.35% | |
| ₹570.00 | ₹598.00 | ₹530.30 | ₹558.65 | -1.99% | |
| ₹501.00 | ₹588.00 | ₹489.25 | ₹571.20 | +14.01% | |
| ₹580.00 | ₹590.75 | ₹486.00 | ₹493.65 | -14.89% | |
| ₹570.10 | ₹657.00 | ₹568.75 | ₹596.75 | +4.67% | |
| ₹668.55 | ₹676.50 | ₹575.00 | ₹583.75 | -12.68% | |
| ₹680.20 | ₹705.45 | ₹627.60 | ₹668.55 | -1.71% | |
| ₹720.60 | ₹744.00 | ₹679.00 | ₹680.95 | -5.50% | |
| ₹712.00 | ₹760.15 | ₹693.55 | ₹724.10 | +1.70% |
Returns & Performance
Return on Equity (ROE)
Profit generated per ₹1 of shareholder equity
Return on Capital (ROCE)
Returns generated on total capital deployed
Oper. Profit Margin (5Y Avg)
Average operating profit margin over 5 years
Dividend Yield
Annual dividend as % of current share price
Amrutanjan Health Care Limited Valuation Check
Price to Earnings (P/E)
Share price ÷ earnings per share. Lower = cheaper
Industry Avg P/E
Average P/E of all peers in this sector
Market Capitalisation
Total market value of all outstanding shares
Growth Engine
Profit Growth (Quarterly YoY)
Net profit growth vs same quarter last year
Revenue Growth (Quarterly YoY)
Revenue growth vs same quarter last year
Revenue Growth (5-Year CAGR)
Compounded annual revenue growth over 5 years
EPS Growth (5-Year CAGR)
Earnings per share growth over 5 years
Net Profit Growth (5-Year CAGR)
Compounded annual net profit growth over 5 years
Balance Sheet Health
Debt to Equity Ratio
Total debt ÷ equity. Below 0.5 = financially healthy
Interest Coverage Ratio
EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably
Free Cash Flow (5-Year Total)
Cash left after capex over 5 years. Positive = self-funded growth
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Amrutanjan Health Care Limited Fundamental Analysis & Valuation Benchmarking
Educational evaluation of AMRUTANJAN across key market metrics for learning purposes.
Positive Indicators
9 factors identified
Strong Return on Equity (16.62%)
Observation: Efficient use of shareholders' capital generating superior returns.
Analysis: ROE >15% indicates strong profitability and effective management. This metric suggests the company can generate substantial returns on invested capital.
Excellent ROCE Performance (21.70%)
Observation: Superior returns on capital employed across business operations.
Analysis: ROCE >15% demonstrates efficient capital deployment and strong operational performance.
Strong Operating Margins (16.63%)
Observation: Healthy 5-year operating margins indicate pricing power and cost control.
Analysis: OPM >15% suggests operational efficiency and competitive advantages.
Attractive Valuation (P/E: 26.27 vs Industry: 34.89)
Observation: Trading at discount to industry peers.
Analysis: P/E below industry average may present value opportunity.
Debt-Free Balance Sheet (D/E: 0.00)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns.
Strong Interest Coverage (400.42x)
Observation: Earnings comfortably cover interest obligations.
Analysis: Interest coverage >5x indicates low financial distress risk.
Healthy Liquidity Position (Current Ratio: 3.44)
Observation: Strong short-term liquidity to meet obligations.
Analysis: Current ratio >1.5 indicates good working capital management.
Strong Cash Generation (₹57.49 Cr over 5Y)
Observation: Healthy free cash flow generation supports growth and returns.
Analysis: Strong FCF provides flexibility for dividends, debt reduction, and growth investments.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
3 factors identified
Profit Decline Concern (-47.47%)
Observation: Significant year-over-year profit contraction observed.
Analysis: Declining profitability requires investigation into underlying causes.
Weak Earnings Growth (-0.88% CAGR)
Observation: Below-average 5-year EPS growth performance.
Analysis: Low EPS growth may not keep pace with inflation.
Stagnant Profit Growth (-1.09% CAGR)
Observation: Limited 5-year profit growth trajectory.
Analysis: Low profit growth may indicate scalability challenges or market maturity.
Amrutanjan Health Care Limited vs Pharmaceuticals Peers
Peer Comparison - Pharmaceuticals
Compare Amrutanjan Health Care Limited with 10 other companies in the same sector
| Company Info | Fundamental | Valuation | Profitability | Financial Health | Growth | Dividend | ||||
|---|---|---|---|---|---|---|---|---|---|---|
Company Company name | Score Bull Run comprehensive fundamental score based on 20+ metrics | Price Current trading price of the stock | Market Cap Total value of all shares in the market | P/E Price per share divided by earnings per share | ROE Net income divided by shareholder equity | ROCE Earnings before interest and tax divided by capital employed | Debt/Eq Total debt divided by total equity | Profit 5Y Average annual profit growth over 5 years | Sales 5Y Average annual sales growth over 5 years | Dividend Annual dividend per share divided by price per share |
Amrutanjan Health Care LimitedAmrutanjan Heal...Selected✓ AMRUTANJAN • 590006 | 58.8/100 | ₹490.40₹490 | ₹1417.80₹1417.80 | 26.27Average 26.3 Average | 16.62%Good 16.62% Good | 21.70%Excellent 21.70% Excellent | 0.00Excellent 0.0 Excellent | -1.09%Poor -1.09% Poor | 8.59%Good 8.59% Good | 0.86% |
Sun Pharmaceutical Industries LimitedSun Pharmaceuti... SUNPHARMA • 524715 | 66.4/100 | ₹1867.00₹1867 | ₹447949.31₹447949.31 | 37.04Average 37.0 Average | 14.74%Average 14.74% Average | 19.31%Good 19.31% Good | 0.05Excellent 0.0 Excellent | 31.64%Excellent 31.64% Excellent | 11.78%Good 11.78% Good | 0.82% |
Divi's Laboratories LimitedDivi's Laborato... DIVISLAB • 532488 | 56.3/100 | ₹9467.00₹9467 | ₹250875.50₹250875.50 | 85.90Average 85.9 Average | 16.19%Good 16.19% Good | 20.38%Excellent 20.38% Excellent | 0.00Excellent 0.0 Excellent | 5.29%Good 5.29% Good | 8.67%Good 8.67% Good | 0.41% |
Torrent Pharmaceuticals LimitedTorrent Pharmac... TORNTPHARM • 500420 | 51.4/100 | ₹4925.00₹4925 | ₹166691.55₹166691.55 | 78.67Average 78.7 Average | 27.07%Excellent 27.07% Excellent | 14.09%Average 14.09% Average | 1.76Average 1.8 Average | 11.56%Good 11.56% Good | 11.80%Good 11.80% Good | 0.76% |
Zydus Lifesciences LimitedZydus Lifescien... ZYDUSLIFE • 532321 | 74.1/100 | ₹1130.90₹1131 | ₹112863.82₹112863.82 | 25.20Average 25.2 Average | 19.74%Good 19.74% Good | 21.77%Excellent 21.77% Excellent | 0.43Excellent 0.4 Excellent | 18.76%Excellent 18.76% Excellent | 12.45%Good 12.45% Good | 0.09% |
Cipla LimitedCipla Limited... CIPLA • 500087 | 40.2/100 | ₹1370.70₹1371 | ₹110732.00₹110732.00 | 32.84Average 32.8 Average | 11.82%Average 11.82% Average | 15.67%Good 15.67% Good | 0.01Excellent 0.0 Excellent | 10.03%Good 10.03% Good | 8.01%Good 8.01% Good | 0.90% |
Laurus Labs LimitedLaurus Labs Lim... LAURUSLABS • 540222 | 34.1/100 | ₹1929.70₹1930 | ₹104252.04₹104252.04 | 95.25Average 95.2 Average | 18.19%Good 18.19% Good | 21.35%Excellent 21.35% Excellent | 0.45Excellent 0.5 Excellent | -1.89%Poor -1.89% Poor | 7.19%Good 7.19% Good | 0.13% |
Aurobindo Pharma LimitedAurobindo Pharm... AUROPHARMA • 524804 | 24.6/100 | ₹1684.00₹1684 | ₹96897.36₹96897.36 | 26.31Average 26.3 Average | 9.94%Poor 9.94% Poor | 14.54%Average 14.54% Average | 0.20Excellent 0.2 Excellent | -8.07%Poor -8.07% Poor | 6.32%Good 6.32% Good | 0.26% |
Lupin LimitedLupin Limited... LUPIN • 500257 | 83.4/100 | ₹2107.20₹2107 | ₹96351.72₹96351.72 | 17.41Average 17.4 Average | 26.90%Excellent 26.90% Excellent | 31.80%Excellent 31.80% Excellent | 0.26Excellent 0.3 Excellent | 34.39%Excellent 34.39% Excellent | 13.02%Good 13.02% Good | 0.72% |
Dr. Reddy's Laboratories LimitedDr. Reddy's Lab... DRREDDY • 500124 | 41/100 | ₹1145.30₹1145 | ₹95632.55₹95632.55 | 29.60Average 29.6 Average | 11.75%Average 11.75% Average | 14.80%Average 14.80% Average | 0.17Excellent 0.2 Excellent | 16.54%Excellent 16.54% Excellent | 12.09%Good 12.09% Good | 0.65% |
Mankind Pharma LimitedMankind Pharma ... MANKIND • 543904 | 61.5/100 | ₹2263.00₹2263 | ₹93461.90₹93461.90 | 45.73Average 45.7 Average | 12.49%Average 12.49% Average | 13.56%Average 13.56% Average | 0.39Excellent 0.4 Excellent | 10.52%Good 10.52% Good | 18.10%Excellent 18.10% Excellent | 0.04% |
Top Pharmaceuticals Stocks
View all →By Bull Run Score
By Return on Equity
By Market Cap
- Sun Pharmaceutical Industries Limited share price447949.31 Cr
- Divi's Laboratories Limited share price250875.50 Cr
- Torrent Pharmaceuticals Limited share price166691.55 Cr
- Zydus Lifesciences Limited share price112863.82 Cr
- Cipla Limited share price110732.00 Cr
Amrutanjan Health Care Limited PE Ratio History
Historical price-to-earnings ratio for AMRUTANJAN — last 5 years
| Year | EPS (₹) | Price (₹) | P/E Ratio |
|---|---|---|---|
| FY 2025 | ₹17.58 | ₹668.55 | 38x |
| FY 2024 | ₹15.50 | ₹722.65 | 46.6x |
| FY 2023 | ₹13.63 | ₹599.45 | 44x |
| FY 2022 | ₹22.98 | ₹710.60 | 30.9x |
P/E = year-end price ÷ diluted EPS from annual filings. Source: NSE/BSE via Bull Run.
Amrutanjan Health Care Limited Dividend History
Annual cash dividends paid by AMRUTANJAN — dividend yield 0.86%
| Financial Year | Dividends Paid (₹ Cr) |
|---|---|
| FY 2025 | ₹13.27 Cr |
| FY 2024 | ₹13.39 Cr |
| FY 2023 | ₹14.41 Cr |
| FY 2022 | ₹12.48 Cr |
Cash dividends from annual cash flow statements. Past dividends do not guarantee future payments. Not investment advice.
Amrutanjan Health Care Limited Quarterly Performance
Latest quarterly metrics for AMRUTANJAN — revenue growth and profit growth vs same quarter last year
Revenue Growth (YoY)
9.49%
Latest quarter vs same quarter previous year
Net Profit Growth (YoY)
-47.47%
Latest quarter net profit vs same quarter previous year
5-Year Revenue CAGR
8.59%
Compounded annual revenue growth over 5 years
5-Year Profit CAGR
-1.09%
Compounded annual net profit growth over 5 years
Amrutanjan Health Care Limited Technical Indicators
SMA 50, SMA 200, RSI and volume signals for AMRUTANJAN — calculated from daily price history
Momentum is balanced — neither overbought nor oversold.
Technical indicators are for educational purposes only. Not investment advice.
Amrutanjan Health Care Limited Financial Statements
Annual income statement, balance sheet and cash flow for Amrutanjan Health Care Limited (AMRUTANJAN) — sourced from NSE/BSE filings.
Financial Results & Statements
Latest quarterly, annual and period-wise financial data for Amrutanjan Health Care Limited
About AMRUTANJAN (Amrutanjan Health Care Limited)
Amrutanjan Health Care Ltd is a venerable Indian pharmaceutical company steeped in tradition, yet dynamically evolving to meet modern healthcare needs. Born from a legacy of Ayurve...dic principles, they craft time-honored remedies designed to alleviate pain and promote wellness. Their familiar yellow tins and distinctive aromas are a household staple, instantly recognizable as a source of comfort and relief from everyday aches and pains. Beyond traditional balms, Amrutanjan has expanded its portfolio to include innovative pain management solutions, adapting to changing consumer preferences and leveraging scientific advancements to enhance efficacy. This commitment to both heritage and innovation positions Amrutanjan as a trusted brand with a contemporary edge. The company's operations span a diverse range of healthcare segments, reflecting a dedication to holistic well-being. From soothing pain balms and convenient roll-ons designed for on-the-go relief, to specialized products addressing joint and muscle discomfort, Amrutanjan caters to a broad spectrum of consumer needs. Recognizing the importance of hygiene and wellness, they've also ventured into the realm of hand sanitizers, providing protection in an increasingly health-conscious world. This strategic diversification highlights Amrutanjan's ability to adapt to market trends and expand its reach beyond traditional pain relief products, demonstrating a forward-thinking approach to business development. Amrutanjan's commitment extends beyond pharmaceuticals, venturing into the beverage sector with offerings that focus on health and hydration. This expansion signifies a strategic move towards preventative wellness, complementing their existing pain relief products. By providing consumers with choices that promote overall well-being, Amrutanjan is solidifying its position as a holistic healthcare provider. This diversified approach, combining traditional remedies, innovative pain management solutions, and wellness-focused beverages, reinforces Amrutanjan's commitment to improving the lives of its consumers, both within India and on an international stage.
Company Details
Key Leadership
AMRUTANJAN Share Price: Frequently Asked Questions
What is the current share price of Amrutanjan Health Care Limited?
Amrutanjan Health Care Limited (AMRUTANJAN) trades at ₹490.40 on NSE and BSE. Market cap ₹1.42K (Cr). Educational data only.
What is the P/E ratio of Amrutanjan Health Care Limited?
Amrutanjan Health Care Limited has a P/E of 26.27x vs industry average 34.89x.
What is the Bull Run score for Amrutanjan Health Care Limited?
Amrutanjan Health Care Limited has a Bull Run score of 58.8/100 based on 25+ financial parameters.
Does Amrutanjan Health Care Limited pay dividends?
Amrutanjan Health Care Limited has a dividend yield of 0.86%. Past dividends don't guarantee future payments.
What is the ROE of Amrutanjan Health Care Limited?
Amrutanjan Health Care Limited has ROE of 16.62%. Higher ROE indicates better use of shareholder equity.
What is the debt-to-equity ratio of Amrutanjan Health Care Limited?
Amrutanjan Health Care Limited has debt-to-equity of 0.00.
Is Amrutanjan Health Care Limited a good investment?
Bull Run gives Amrutanjan Health Care Limited a score of 58.8/100. This is not investment advice — consult a SEBI-registered advisor.